Literature DB >> 9692461

Early pulmonary resection for localized Mycobacterium avium complex disease.

Y Shiraishi1, K Fukushima, H Komatsu, A Kurashima.   

Abstract

BACKGROUND: Results of antituberculous chemotherapy for Mycobacterium avium complex disease remain disappointing. Pulmonary resection during an early stage of the disease, therefore, may be beneficial to patients whose disease is localized and who can tolerate a resectional operation.
METHODS: Thirty-three patients with localized M avium complex disease underwent 33 pulmonary resections between 1979 and 1996. There were 17 males and 16 females, with a mean age of 50 years (range, 30 to 69 years). Lobectomy was performed in 26 patients, pleuropneumonectomy in 1, segmentectomy in 5, and wedge resection in 1.
RESULTS: There was no operative mortality. After pulmonary resection, 31 (94%) patients attained sputum-negative status. Bronchopleural fistula occurred in one patient who underwent a right upper lobectomy. There were two late deaths. A patient with bronchopleural fistula died of respiratory failure two years postoperatively. Another patient died of an unknown cause 12 years postoperatively. Of the 31 patients with negative sputum status postoperatively, only 2 patients (6%) had relapse at 1 and 9 years after operation.
CONCLUSIONS: We recommend that patients with this disease be considered for pulmonary resection as early as possible.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9692461     DOI: 10.1016/s0003-4975(98)00373-7

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  9 in total

Review 1.  Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.

Authors:  Barbara A Brown-Elliott; Kevin A Nash; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

Review 2.  Surgical treatment of nontuberculous mycobacterial lung disease.

Authors:  Yuji Shiraishi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-04-17

3.  Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline.

Authors:  Charles L Daley; Jonathan M Iaccarino; Christoph Lange; Emmanuelle Cambau; Richard J Wallace; Claire Andrejak; Erik C Böttger; Jan Brozek; David E Griffith; Lorenzo Guglielmetti; Gwen A Huitt; Shandra L Knight; Philip Leitman; Theodore K Marras; Kenneth N Olivier; Miguel Santin; Jason E Stout; Enrico Tortoli; Jakko van Ingen; Dirk Wagner; Kevin L Winthrop
Journal:  Eur Respir J       Date:  2020-07-07       Impact factor: 16.671

4.  Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline.

Authors:  Charles L Daley; Jonathan M Iaccarino; Christoph Lange; Emmanuelle Cambau; Richard J Wallace; Claire Andrejak; Erik C Böttger; Jan Brozek; David E Griffith; Lorenzo Guglielmetti; Gwen A Huitt; Shandra L Knight; Philip Leitman; Theodore K Marras; Kenneth N Olivier; Miguel Santin; Jason E Stout; Enrico Tortoli; Jakko van Ingen; Dirk Wagner; Kevin L Winthrop
Journal:  Clin Infect Dis       Date:  2020-08-14       Impact factor: 9.079

5.  Treatment outcomes of adjuvant resectional surgery for nontuberculous mycobacterial lung disease.

Authors:  Hyung Koo Kang; Hye Yun Park; Dohun Kim; Byeong-Ho Jeong; Kyeongman Jeon; Jong Ho Cho; Hong Kwan Kim; Yong Soo Choi; Jhingook Kim; Won-Jung Koh
Journal:  BMC Infect Dis       Date:  2015-02-19       Impact factor: 3.090

Review 6.  Surgery in nontuberculous mycobacteria pulmonary disease.

Authors:  Mimi Lu; Dominic Fitzgerald; Jonathan Karpelowsky; Hiran Selvadurai; Chetan Pandit; Paul Robinson; Ben J Marais
Journal:  Breathe (Sheff)       Date:  2018-12

7.  Outcomes of adjunctive surgery for nontuberculous mycobacterial pulmonary disease.

Authors:  Joong-Yub Kim; Samina Park; In Kyu Park; Chang Hyun Kang; Young Tae Kim; Jaemoon Koh; Jae-Joon Yim; Nakwon Kwak
Journal:  BMC Pulm Med       Date:  2021-10-06       Impact factor: 3.317

8.  The outcomes of anatomical lung resection for nontuberculous mycobacterial lung disease.

Authors:  Tadashi Sakane; Katsunari Matsuoka; Sakiko Kumata; Risa Watanabe; Tetsu Yamada; Takahisa Matsuoka; Shinjiro Nagai; Mitsuhiro Ueda; Yoshihiro Miyamoto
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

9.  Surgical treatment of pulmonary diseases due to nontuberculous mycobacteria.

Authors:  Won-Jung Koh; Yee Hyung Kim; O Jung Kwon; Yong Soo Choi; Kwhanmien Kim; Young Mog Shim; Jhingook Kim
Journal:  J Korean Med Sci       Date:  2008-06       Impact factor: 2.153

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.